Siren »

Natera shares owned by Siren

Quarter-by-quarter ownership of Natera (NTRA) shares owned by Siren from 13F filings

Historical chart of Siren investment in Natera

Tip: Access up to 7 years of quarterly data

All positions including Natera held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Natera by Siren

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.6M 13k 126.95

More positions owned by Siren

Kymera Therapeutics (KYMR)
Beigene Sponsored Adr
Scholar Rock Hldg Corp (SRRK)
Bicara Therapeutics (BCAX)
Argenx SE Sponsored Adr (ARGX)
Crinetics Pharmaceuticals In (CRNX)
Avidity Biosciences Ord (RNA)
Apellis Pharmaceuticals (APLS)
Lexicon Pharmaceuticals Com New (LXRX)
Igm Biosciences (IGMS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Silence Therapeutics Ads (SLN)
Arrowhead Pharmaceuticals (ARWR)
WAVE Life Sciences SHS (WVE)

View all positions for Siren

Top funds holding Natera

BlackRock
Jpmorgan Chase & Co
Fred Alger Management
Duquesne Family Office
T. Rowe Price Associates
Massachusetts Financial Services
Citadel Advisors
Invesco
Geode Capital Management
Sofinnova Ventures
Lord, Abbett & Co
American Century Companies
Maverick Capital
Allspring Global Investments Holdings
Franklin Resources

View all funds holding Natera